BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Everest Medicines Ends Collaboration with Providence, Gains Full Rights to mRNA Products

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...

February 19, 2024 | News

Multiply Labs, Thermo Fisher Expand Partnership for Cell Therapy Automation

Through integration with Multiply Labs' robotic technology, Thermo Fisher Scientific’s advanced, industry-leading cell therapy instruments, including...

February 13, 2024 | News

AstraZeneca Boosts US Manufacturing to Accelerate Cell Therapy Advancements

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critic...

February 07, 2024 | News

WuXi Biologics Achieves Milestone with 16,000L Manufacturing Run in Ireland

First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...

February 01, 2024 | News

Cognizant Strengthens Partnership with Takeda for Joint Digital Transformation and Innovation Center Expansion

Cognizant announced an expanded agreement with Takeda , a global biopharmaceutical company, to support the company's digital transform...

January 26, 2024 | News

Singapore's GDMC Raises $21M to Boost Global Genetic Therapy Manufacturing

Funding is led by existing investor Celadon Partners with participation from SEEDS Capital, NSG Ventures and WI Harper Group GDMC aims to use the ...

January 26, 2024 | News

AbbVie Invests $223M to Expand Biologics Manufacturing in Singapore

US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 emp...

January 26, 2024 | News

WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services

Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...

January 24, 2024 | News

Sagimet Biosciences Reports Positive Results in Phase 2b Trial of Denifanstat for F2/F3 NASH

- Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in ...

January 24, 2024 | News

Kindeva Drug Delivery Acquires Summit Biosciences, a Nasal Drug Development Specialist

The acquisition of Summit enhances Kindeva’s existing drug-delivery capabilities by adding a new drug-delivery platform, further expanding Kindeva&rs...

January 19, 2024 | News

Thermo Fisher Scientific Introduces First Off-the-Shelf Validated Software for Automated Cell Therapy Manufacturing

To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the laun...

January 18, 2024 | News

Charles River Streamlines AAV Vector Manufacturing with Rep/Cap Plasmids Launch

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...

January 17, 2024 | News

Boehringer Ingelheim Invests EUR 120 Million in Greek Plant Expansion for Enhanced Medication Manufacturing and Job Creation

Main disease areas include cardio-renal-metabolic (CRM) diseases, mental health, pulmonary fibrosis, systemic sclerosis, and chronic liver disease, some of...

January 12, 2024 | News

GBI Strengthens Radiopharmaceutical Manufacturing Leadership with Commercial Manufacturing Contract

"We are thrilled to announce the signing of our second commercial contract, a testament to the exceptional capabilities and unwavering commitment of the en...

January 11, 2024 | News

Stay Connected